Dr. Lance C. Pagliaro, MD

  • Rochester, MN
  • Medical oncologist
NPI1568553311PAC ID0143414458
Medicare services, 2024
16,232
Medicare patients, 2024
271
Part D claims, 2024
441
Publications
104
Clinical trials
1
Practice address
200 First Street SW, Rochester, MN 55905
Practice phone
Call (507) 284-5968
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Mayo Clinic Breast Diagnostic Clinic

Mammography / Breast Imaging Center · Rochester, Minnesota

See all 5 affiliations

Find Dr. Pagliaro's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Lance C. Pagliaro is a medical oncologist in Rochester, Minnesota

Dr. Pagliaro practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Pagliaro's NPI, 1568553311, was assigned on September 27, 2006. Dr. Pagliaro graduated from Albany Medical College of Union University in 1987. Dr. Pagliaro holds Minnesota license 59518.

NPI and contact details
Medicare PAC ID
0143414458
NPI enumeration date
September 27, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(507) 284-5968
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
65
Medical school graduation
1987

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Lance C. Pagliaro practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota

Dr. Pagliaro's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

  • Mayo Clinic Breast Diagnostic Clinic
    200 First Street SW, Rochester, MN 55905Phone(507) 284-5968

Source: Dmand AI Affiliation Data

Dr. Lance C. Pagliaro is affiliated with 4 sites of care and 1 medical group

Dr. Pagliaro's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Pagliaro is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Pagliaro to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Pagliaro's employer is on file too: a breast imaging center.

See all 5 affiliations for Dr. Pagliaro

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Lance C. Pagliaro's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pagliaro practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Mayo Clinic Breast Diagnostic ClinicAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Pagliaro practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Lance C. Pagliaro is one of 122 medical oncologists in Minnesota

Medical oncology is Dr. Pagliaro's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Pagliaro's licenses on file in 2 states: Minnesota and Texas.

Specialties and state licenses

  • Medical oncology, MinnesotaPrimaryLicense 59518 · taxonomy 207RX0202X
  • Hematology and oncology, TexasLicense J2721 · taxonomy 207RH0003X

Medical oncologists near Dr. Pagliaro

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Lance C. Pagliaro billed Medicare for 16,232 services in 2024

CMS data shows 16,232 Medicare services from Dr. Pagliaro across 27 procedure codes in 2024, for 271 Medicare patients. Medicare paid $352,077 for them. Every service was in an office.

Medicare services, 202416,232
Medicare patients271
Paid by Medicare$352,077
Procedure codes27

Dr. Pagliaro's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 13,7922024: 15,52713%
Tests and treatments
2023: 3082024: 47454%
Office and hospital visits
2023: 2492024: 19123%
Other services
2023: 02024: 40

Dr. Pagliaro compared with the Minnesota median for medical oncologists, 2024

  • Dr. Pagliaro
  • Minnesota median
Medicare services
16,232vs 1,28412.6 times
Medicare patients
271vs 2489% above
Part D claims
363vs 19685% above

Medians across 119 medical oncologists in Minnesota with Dmand AI profiles that report each measure.

Dr. Pagliaro's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Pagliaro

Need commercial claims for Dr. Pagliaro?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pagliaro and other medical oncologists in Minnesota.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Lance C. Pagliaro treated 271 Medicare patients in 2024, average age 74

CMS counts 271 Medicare patients who saw Dr. Pagliaro in 2024. The largest group is 65 to 74, with 140 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pagliaro's median patient age at 70, with 30% women.

Medicare patients, 2024271
Average age74
Average risk score2.50
Also on Medicaid5%

Dr. Pagliaro's Medicare patients by age, 2024

Dr. Pagliaro's Medicare patients by sex, 2024

  • Women10137%
  • Men17063%

Chronic conditions among Dr. Pagliaro's Medicare patients, 2024

  1. High blood pressure69%
  2. High cholesterol64%
  3. Cancer61%
  4. Arthritis39%
  5. Chronic kidney disease38%
  6. Ischemic heart disease30%
  7. Diabetes26%
  8. Atrial fibrillation24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Pagliaro's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women30%
  • Men71%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Lance C. Pagliaro wrote 441 Medicare Part D claims in 2024

In 2024, Dr. Pagliaro wrote 441 Medicare Part D claims for 70 patients. 67% of them were for generic drugs. CMS names the drug for 363 of them, across 12 drugs with 11 or more claims each, at $2,440,924 in total drug cost. In 2023, CMS named 302 claims across 10 drugs.

Part D claims, 2024441
Drugs named by CMS12
Total drug cost$2.4M
Part D patients70

Dr. Pagliaro's Part D claims by kind of drug, 2024

  • Generic294 claims67%
  • Brand-name147 claims33%

Dr. Pagliaro's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Pagliaro's Part D claims, 2024

  • Opioids6%26 of 441 claims
  • Antibiotics4%16 of 441 claims
  • Antipsychotics, patients 65 and over9%39 of 441 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3022024: 36320%

Drugs named by CMS: 12 in 2024, 10 in 2023.

See all prescribing by Dr. Pagliaro

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Lance C. Pagliaro offers telehealth to Medicare patients

Dr. Pagliaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pagliaro as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Pagliaro by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Lance C. Pagliaro has 104 publications on record

Dmand AI links 104 papers to Dr. Pagliaro, published from 2003 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Penile Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Neoplasm Metastasis. Dr. Pagliaro has published most often in Clin Genitourin Cancer. Dr. Pagliaro's most frequent co-authors are Stephen Anthony Boorjian, MD, Brian A. Costello, MD and Philippe E. Spiess, MD.

Papers104
Years published2003 to 2025

Dr. Pagliaro's papers by year, 2016 to 2025

Topics Dr. Pagliaro writes about most

  • Penile Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasm Metastasis
  • Prostatic Neoplasms, Castration-Resistant
  • Biomarkers, Tumor
  • Carcinoma, Squamous Cell
  • Antineoplastic Agents
  • Carcinoma, Renal Cell

Dr. Pagliaro's most frequent co-authors

Recent publications by Dr. Pagliaro

See all 104 publications and co-authors

See who Dr. Pagliaro researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pagliaro works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Lance C. Pagliaro has worked on 1 clinical trial

Dmand AI links Dr. Pagliaro to 1 clinical trial. Conditions studied include Clear-cell metastatic renal cell carcinoma and Carcinoma, Renal Cell.

Conditions in Dr. Pagliaro's trials

  • Clear-cell metastatic renal cell carcinoma
  • Carcinoma, Renal Cell

Recent clinical trials with Dr. Pagliaro

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Lance C. Pagliaro received $46,157 in industry payments from 2016 to 2022

CMS Open Payments shows 64 general payments to Dr. Pagliaro from 4 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 83% of the total. Merck Sharp & Dohme Corporation paid the most, $41,954.

General payments to Dr. Pagliaro by program year, 2016 to 2022

General payments to Dr. Pagliaro by kind, 2016 to 2022

$46.2Kin total
  • Consulting fees$38,12383%
  • Travel and lodging$6,31014%
  • Food and beverage$1,5523%
  • Accredited education speaker fees$1720%

Companies that paid Dr. Pagliaro the most, 2016 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Pagliaro

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Lance C. Pagliaro graduated from Albany Medical College of Union University

Dr. Pagliaro graduated from Albany Medical College of Union University in 1987.

  1. Medical schoolAlbany Medical College of Union University

Source: Dmand AI Professional Profile Data

Sources for Dr. Lance C. Pagliaro's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Lance C. Pagliaro

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Lance C. Pagliaro's NPI number?

Dr. Lance C. Pagliaro's NPI number is 1568553311. It was assigned on September 27, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Lance C. Pagliaro?

Dr. Lance C. Pagliaro is a medical oncologist in Rochester, Minnesota. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Lance C. Pagliaro practice?

Dr. Pagliaro practices at 200 First Street SW, Rochester, MN 55905. Dr. Pagliaro's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dmand AI also links Dr. Pagliaro to 1 clinical lab and 1 hospice.

What is Dr. Lance C. Pagliaro's office phone number?

The practice phone on file for Dr. Pagliaro is (507) 284-5968.

What is Dr. Lance C. Pagliaro's medical license number?

Dr. Pagliaro holds Minnesota license 59518, one of the licenses on file in 2 states.

Which states has Dr. Lance C. Pagliaro been licensed in?

Dmand AI has state licenses on file for Dr. Pagliaro in Minnesota and Texas.

Which hospitals is Dr. Lance C. Pagliaro affiliated with?

Dr. Pagliaro is affiliated with Mayo Clinic Hospital, Saint Marys Campus.

What medical group is Dr. Lance C. Pagliaro part of?

Dr. Pagliaro is linked to Mayo Clinic.

Does Dr. Lance C. Pagliaro accept Medicare?

Yes. CMS data shows Dr. Pagliaro billed Medicare for 16,232 services in 2024, and Dr. Pagliaro accepts Medicare assignment.

Does Dr. Lance C. Pagliaro offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Pagliaro as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Lance C. Pagliaro see?

CMS counts 271 Medicare patients who saw Dr. Pagliaro in 2024, with an average age of 74.

What services does Dr. Lance C. Pagliaro bill to Medicare?

In 2024, Dr. Pagliaro's most billed Medicare services were injected or infused drug (J9144), injected or infused drug (J9271) and injected or infused drug (J9267).

Where did Dr. Lance C. Pagliaro go to medical school?

Dr. Pagliaro graduated from Albany Medical College of Union University in 1987.

What drugs does Dr. Lance C. Pagliaro prescribe most?

In 2024 Medicare Part D data, Dr. Pagliaro's most prescribed drugs by claims were Xtandi, Dexamethasone and Olanzapine.

Has Dr. Lance C. Pagliaro received payments from drug or device companies?

CMS Open Payments shows $46,157 in general payments to Dr. Pagliaro from 4 companies from 2016 to 2022. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Lance C. Pagliaro been practicing?

Dr. Pagliaro graduated from medical school in 1987, 39 years ago.

Does Dr. Lance C. Pagliaro do research?

Dmand AI links 104 publications to Dr. Pagliaro, published from 2003 to 2025. Dr. Pagliaro has worked on 1 clinical trial.

Who does Dr. Lance C. Pagliaro publish with?

Dr. Pagliaro's most frequent co-authors are Stephen Anthony Boorjian, MD (18 shared papers), Brian A. Costello, MD (18 shared papers) and Philippe E. Spiess, MD (11 shared papers).

Selling to medical oncology practices?

See medical oncologists in Minnesota by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)